Call us
+44 1204 543 529
Pharmaceuticals and Healthcare

Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends

Report code: GDHC001MAL
Published: Nov-2012
Formats:
  • Adobe PDF
Number of pages: 75
Description
Highlights
Key Benefits
Contents
Samples
  • GlobalData’s Biotech Strategy 2012: Licensing, Collaboration, and M&A Trends report analyzes 20 strategic deals struck by leading and promising biotech companies. The terms and strategic drivers of these deals are analyzed based on acquisition costs, strategic fit, potential revenues, competitive advantage as well as other measures to illustrate the strategies different companies are currently using to gain market share, increase shareholder value and bring innovative and life-saving products to the booming global pharmaceuticals market. This report is an essential source of information and analysis on global strategic deals involving the top players in the global pharmaceuticals market.

    Scope

    The report provides full details of 20 significant deals from Q3 2011 to Q3 2012 involving promising biotech companies including deal terms and payment structure.

    The report provides analysis of the key drivers, trends, and strategies behind deals undertaken by biotech companies across important geographic regions including the US, EU, Asia-Pacific, Brazil, Russia, India, China, and other emerging markets.

    The report covers the six major therapy areas of cardiovascular disease, central nervous system (CNS), diabetes and metabolic, immunology, oncology, and respiratory.

    The report contains expert insights on the corporate strategies of emerging biotech companies seeking competitive advantage in the pharmaceuticals marketplace.

    About The Report

    The Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends report is an essential source of information and analysis on global strategic deals involving the top players in the global pharmaceuticals market. Using detailed company data and financial analysis, GlobalData has highlighted certain deals in the pharmaceuticals market, forming a basis for in-depth analysis of the factors driving deal-making in the industry, currently and into the future. The report discusses the key factors shaping and driving the global pharmaceutical industry, and provides insight on the competitive landscape and emerging strategies that are expected to significantly alter the market position of industry leaders.

  • Request Sample Pages

  • ?
    Electronic PDF copy delivered via email.

    Report can be used by individual purchaser only.

    $2995
  • ?
    Electronic PDF copy delivered via email.

    Report can be shared by unlimited users within one corporate location,
    e.g. a regional office.

    $5990
  • ?
    Electronic PDF copy delivered via email.

    Report can be shared globally by unlimited users within the purchasing corporation
    e.g. all employees of a single company.

    $8985
Add to cart

Talk to us

Call us on +44 1204 543 529

Research Support

Get one-to-one support from our expert analysts only when you buy direct

Price Guarantee

You will not find our reports cheaper anywhere else

Customer Focused

Our client support team are on-hand to assist with your research needs

Unrivalled Expertise

700+ analysts delivering actionable insight